StockData
Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd (RDY) stock

RDYNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Score 7/30
$14.98+0.19 (+1.28%)

Close on Nov 18, 2026Market cap $12.50BP/E 27.5Yield 0.57%

Dr Reddys Laboratories shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

For fiscal 2026 it was 833M, down 0.1% from the year before. Over ten years it grew -0.3% a year on average. The highest annual figure on record is 855M in fiscal 2016.

Annual shares outstanding

PeriodPeriod endValueChange
FY2026Mar 31, 2026833M-0.1%
FY2025Mar 31, 2025834M+0.1%
FY2024Mar 31, 2024834M+0.2%
FY2023Mar 31, 2023832M+0.0%
FY2022Mar 31, 2022832M+0.0%
FY2021Mar 31, 2021832M+0.1%
FY2020Mar 31, 2020830M-0.1%
FY2019Mar 31, 2019831M+0.0%
FY2018Mar 31, 2018831M-0.5%
FY2017Mar 31, 2017835M-2.4%
FY2016Mar 31, 2016855M–

More Dr Reddys Laboratories figures

See a number that looks wrong?